# Telo Genomics Corp. (TDSGF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TDSGF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.63M | $ -1.07M | $ 1.32M | $ -972.7K |
| 2025 | $ 0 | $ -2.53M | $ -2.33M | $ 0 | $ 515.0K |
| 2024 | $ 0 | $ -2.76M | $ -2.51M | $ 0 | $ 590.1K |
| 2023 | $ 0 | $ -2.93M | $ -2.80M | $ 32.5K | $ 2.61M |
| 2022 | $ 0 | $ -2.26M | $ -1.95M | $ 40.0K | $ 2.60M |
| 2021 | $ 0 | $ -1.22M | $ -1.27M | $ 40.0K | $ 3.69M |
| 2020 | $ 0 | $ -1.62M | $ -1.34M | $ 40.0K | $ 775.3K |
| 2019 | $ 0 | $ -1.29M | $ -394.8K | $ 280.0K | $ -1.04M |
| 2018 | $ 0 | $ -5.78M | $ -7.16M | N/A | $ -314.0K |
| 2017 | $ 0 | $ -12.45M | $ -10.52M | N/A | $ 2.23M |
| 2016 | $ 0 | $ -148.8K | $ -191.7K | $ 345.3K | $ 510.2K |
| 2015 | $ 0 | $ -51.7K | $ -49.0K | $ 202.7K | $ 436.8K |
| 2014 | $ 0 | $ -135.3K | $ -133.5K | $ 0 | $ 476.6K |
| 2013 | $ 0 | $ -46.2K | $ -56.7K | $ 0 | $ 519.2K |
| 2012 | $ 0 | $ -135.0K | $ -60.9K | $ 0 | $ 553.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.36 |
| Liabilities / Eq | -2.26 |
| Current Ratio | 0.49 |

## Other views

- [Metrics](https://sponda.capital/en/TDSGF.md)
- [Charts](https://sponda.capital/en/TDSGF/charts.md)
- [Compare](https://sponda.capital/en/TDSGF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.